Quan, Lili
Ohgaki, Ryuichi
Hara, Saori
Okuda, Suguru
Wei, Ling
Okanishi, Hiroki
Nagamori, Shushi
Endou, Hitoshi
Kanai, Yoshikatsu https://orcid.org/0000-0001-8126-286X
Funding for this research was provided by:
Pharmacological Research Foundation, Tokyo
JSPS Grant-in-Aid for Scientific Research (18K06931)
JSPS Grants-in-Aid for Scientific Research (19H03407)
Project for Cancer Research And Therapeutic Evolution from AMED (JP17cm0106118)
Project for Cancer Research And Therapeutic Evolution from AMED (JP18cm0106131)
Project for Cancer Research And Therapeutic Evolution from AMED (JP19cm0106151)
Project for Cancer Research And Therapeutic Evolution from AMED (JP20cm0106151)
Advanced Research for Medical Products Mining Program of NIBIO (12-02)
Translational Research Network Program from MEXT (H25B7)
Collaborative Research Grant from J-Pharma Co., Ltd.
Article History
Received: 31 August 2020
Accepted: 3 November 2020
First Online: 30 November 2020
Ethics approval and consent to participate
: Animal experiments were conducted in compliance with the protocols approved by the Osaka University Medical School Animal Care and Use Committee.
: No applicable.
: Y.K. received collaborative research grant from J-Pharma Co., Ltd. H.E. is Founder of J-Pharma Co., Ltd. and has led the development of JPH203. Other authors declare no competing interests.